Toyonaka, Japan

Masaya Tohyama

This inventor holds 2 USPTO granted patents. Top assignees: Japan Science and Technology Agency, Tanabe Seiyaku Company, Limited. Active years: 2003-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaya Tohyama. Retrieved from https://idiyas.com/inventor/masaya-tohyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masaya Tohyama: Innovator in Neurodegenerative Disease Research

Introduction

Masaya Tohyama is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of neurodegenerative diseases, particularly through his innovative research and patents. With a total of 2 patents, Tohyama's work focuses on understanding and addressing the complexities of diseases such as Alzheimer's.

Latest Patents

Tohyama's latest patents include groundbreaking inventions aimed at treating and preventing diseases caused by aberrant splicing. One of his notable patents is related to a nucleic acid that participates in the formation of a presenilin-2-gene exon 5-defective splicing variant. This invention provides a means for treatment and/or prevention of neurodegenerative diseases, including Alzheimer's disease. It involves a nucleic acid associated with the generation of a splice variant that lacks exon 5 of the presenilin-2 gene, along with an inhibitor that can prevent the binding between protein and nucleic acid caused by aberrant splicing.

Another significant patent focuses on methods for examining central nervous system diseases and screening remedies. This invention outlines a method for screening and identifying therapeutic or preventive agents for central nervous system diseases by assessing the suppressing effect of a test substance on the expression of a splicing variant transcribed from the presenilin-2 gene. It also includes a method for detecting the expression of this splicing variant in test samples from animal individuals.

Career Highlights

Throughout his career, Masaya Tohyama has worked with esteemed organizations such as Tanabe Seiyaku Company, Limited and the Japan Science and Technology Agency. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Tohyama has collaborated with notable colleagues, including Tsutomu Takagi and Naoya Sato. These partnerships have further enriched his research endeavors and have led to innovative solutions in the field of neurodegenerative diseases.

Conclusion

Masaya Tohyama's contributions to the understanding and treatment of neurodegenerative diseases are invaluable. His innovative patents and collaborative efforts highlight his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…